Three-Dimensionally Printed Paediatric Medicines: Formulation, Process, and Regulatory Considerations
Pharmaceutics · 19.12.2025 · 18 (1) · 2
DOI: 10.3390/pharmaceutics18010002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 19.12.2025. Verfasst von Krisztina Petrinca und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Eötvös Street 6, 6720 Szeged, Hungary. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Academy of Scientist Education Program of the National Biomedical Foundation under the sponsorship of the Hungarian Ministry of Culture and Innovation, National Academy of Science Education Program, National Biomedical Foundation.
Abstract (Originalsprache)
Paediatric formulations are pharmaceutical dosage forms specifically designed to meet the physiological, developmental, pharmacokinetic, and practical needs of patients from birth to adolescence. Developing safe, effective, and age-appropriate medicines for children remains a significant challenge due to their age-dependent variability in physiological development, pharmacokinetic profiles, and therapeutic needs. These differences, combined with practical barriers such as poor palatability, limited swallowability, inappropriate dosage form size, and instability, often lead to the modification of adult medicines—practices that can cause dosing inaccuracies, contamination risks, and reduced therapeutic efficacy. Three-dimensional printing has emerged as a promising solution to address these limitations by creating personalised paediatric dosage forms with adjustable strengths, multilayer structures for controlled release, and child-friendly shapes that may improve acceptability and adherence. This review offers an overview of the physiological, technological, and regulatory factors involved in developing 3D-printed paediatric medicines. The Critical Quality and Performance Attributes relevant to this field—including dose accuracy and flexibility, release kinetics, palatability, product dimensions, material choice, safety, stability, cost-effectiveness, production time, scalability, and reproducibility—are discussed in the article. Additionally, the review discusses the evolving Good Manufacturing Practice and regulatory landscape necessary to ensure the quality, safety, and consistency of 3D-printed medicinal products. Overall, these insights underline the transformative potential of 3D printing as a pathway towards safer, more effective, and truly personalised pharmacotherapy for paediatric patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Eötvös Street 6, 6720 Szeged, Hungary.
ORCID-Profile: Zsófia Németh, Ildikó Csóka, Rita Ambrus, Orsolya Jójárt-Laczkovich
Förderung
- National Academy of Scientist Education Program of the National Biomedical Foundation under the sponsorship of the Hungarian Ministry of Culture and Innovation
- National Academy of Science Education Program
- National Biomedical Foundation
- Hungarian Ministry of Culture and Innovation
- Ministry of Culture and Innovation of Hungary
- National Research, Development and Innovation Fund
- University of Szeged Open Access Fund
Zitieren
APA
Petrinca, K., Németh, Z., Csóka, I., Ambrus, R., & Jójárt-Laczkovich, O. (2025). Three-Dimensionally Printed Paediatric Medicines: Formulation, Process, and Regulatory Considerations. Pharmaceutics, 18(1), 2. https://doi.org/10.3390/pharmaceutics18010002
Vancouver
Petrinca K, Németh Z, Csóka I, Ambrus R, Jójárt-Laczkovich O. Three-Dimensionally Printed Paediatric Medicines: Formulation, Process, and Regulatory Considerations. Pharmaceutics. 2025;18(1):2. doi:10.3390/pharmaceutics18010002
BibTeX
@article{Petrinca2025,
author = {Petrinca, Krisztina and Németh, Zsófia and Csóka, Ildikó and Ambrus, Rita and Jójárt-Laczkovich, Orsolya},
title = {Three-Dimensionally Printed Paediatric Medicines: Formulation, Process, and Regulatory Considerations},
journal = {Pharmaceutics},
year = {2025},
volume = {18},
number = {1},
pages = {2},
doi = {10.3390/pharmaceutics18010002}
}
EUVIMED